gentamicin c1a has been researched along with amphotericin b in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, LJ; Bewley, CA; Liu, H; Lohith, K; O'Connor, RD; Pulliam, TH; Rosario, M | 1 |
| Augusto, O; Coelho, FR; Ferreira, EI; Miyata, M; Segretti, MC; Segretti, ND; Serafim, RA | 1 |
| Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Konečná, K; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Valášková, L; Vávrová, K | 1 |
| Benková, M; Hrabálek, A; Karabanovich, G; Kavková, V; Klimešová, V; Konečná, K; Macháček, M; Němeček, J; Roh, J; Soukup, O; Stolaříková, J; Sychra, P; Vávrová, K | 1 |
| Chauhan, CS; Dandia, A; Indora, A; Khan, S; Mahawar, DK; Pandya, P; Soni, P | 1 |
| Chou, S; Dou, X; Shan, A; Song, J; Wang, J; Wang, Z; Yang, Y; Yang, Z | 1 |
| Chen, S; He, S; Liu, X; Qiu, G; Shi, J; Tang, W; Wu, X; Xu, K; Zhang, J | 1 |
| Zhang, B | 1 |
| Bai, H; Chen, L; Zhang, J; Zheng, S; Zhou, X; Zhu, R | 1 |
| Abutaleb, NS; Hagras, M; Kotb, A; Mayhoub, AS; Salama, EA; Sayed, AM; Seleem, MN | 1 |
| Al-Ghorbani, M; Alsayari, A; Asiri, YI; Mabkhot, YN; Muhsinah, AB; Venkatesan, K | 1 |
| Alsarraf, J; Legault, J; Pichette, A; Plourde, J; St-Gelais, A | 1 |
1 review(s) available for gentamicin c1a and amphotericin b
| Article | Year |
|---|---|
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
11 other study(ies) available for gentamicin c1a and amphotericin b
| Article | Year |
|---|---|
Polybrominated Diphenyl Ethers: Structure Determination and Trends in Antibacterial Activity.
Topics: Animals; Anti-Bacterial Agents; Dysidea; Enterococcus faecium; Escherichia coli; Halogenated Diphenyl Ethers; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Papua New Guinea; Staphylococcus aureus; Structure-Activity Relationship | 2016 |
New antibacterial agents: Hybrid bioisoster derivatives as potential E. coli FabH inhibitors.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Acetyltransferases; Animals; Anti-Bacterial Agents; Binding Sites; Candida albicans; Catalytic Domain; Cell Survival; Chlorocebus aethiops; Enzyme Inhibitors; Escherichia coli; Escherichia coli Proteins; Fatty Acid Synthase, Type II; Hydrogen Bonding; Microbial Sensitivity Tests; Molecular Docking Simulation; Oxadiazoles; Static Electricity; Structure-Activity Relationship; Vero Cells | 2016 |
S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents.
Topics: Antifungal Agents; Antitubercular Agents; Drug Design; Drug Resistance; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Sulfhydryl Compounds; Tetrazoles | 2017 |
Structure-activity relationship studies on 3,5-dinitrophenyl tetrazoles as antitubercular agents.
Topics: Antitubercular Agents; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Species Specificity; Structure-Activity Relationship; Tetrazoles | 2017 |
Diversity-oriented sustainable synthesis of antimicrobial spiropyrrolidine/thiapyrrolizidine oxindole derivatives: New ligands for a metallo-β-lactamase from Klebsiella pneumonia.
Topics: Anti-Bacterial Agents; beta-Lactamases; Dose-Response Relationship, Drug; Indoles; Klebsiella pneumoniae; Ligands; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Oxindoles; Protein Binding; Pyrrolidines; Spiro Compounds; Structure-Activity Relationship; Substrate Specificity | 2017 |
Combating Drug-Resistant Fungi with Novel Imperfectly Amphipathic Palindromic Peptides.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Candida albicans; Cytoplasm; Drug Resistance, Fungal; HEK293 Cells; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Intracellular Membranes; Inverted Repeat Sequences; Mice; Models, Molecular; Peptides; Protein Conformation; RAW 264.7 Cells | 2018 |
Free radical rearrangement synthesis and microbiological evaluation of novel 2-sulfoether-4-quinolone scaffolds as potential antibacterial agents.
Topics: Anti-Bacterial Agents; Bacillus cereus; Dose-Response Relationship, Drug; Free Radicals; Hydrogen Bonding; Microbial Sensitivity Tests; Molecular Structure; Quinolones; Staphylococcus aureus; Structure-Activity Relationship | 2018 |
Synthesis and biological evaluation of calycanthaceous alkaloid analogs.
Topics: Acetylcholinesterase; Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cholinesterase Inhibitors; Fungi; Indole Alkaloids; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Protein Binding; Pyrroles; Structure-Activity Relationship; Torpedo | 2019 |
Oxadiazolylthiazoles as novel and selective antifungal agents.
Topics: Antifungal Agents; Aspergillus; Biofilms; Caco-2 Cells; Candida; Cryptococcus; Humans; Microbial Sensitivity Tests; Oxadiazoles; Stereoisomerism; Thiazoles | 2020 |
Design, synthesis and antimicrobial activity of novel 2-aminothiophene containing cyclic and heterocyclic moieties.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thiophenes | 2021 |
Effect of the Chromone Core Substitution of Dirchromone on the Resultant Biological Activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Cell Line, Tumor; Chromones; Humans; Structure-Activity Relationship | 2021 |